Department of Pediatrics

Children’s Hospital doctors and nurses brought flu vaccines to underserved areas in Nashville through its “Mobile Flu Fighter!” project.
January 27, 2022

Children’s Hospital program brought flu vaccines to underserved areas

By Christina Echegaray
January 20, 2022

Education, school quality top concerns for parents: poll

A new poll of Tennessee parents from the Vanderbilt Center for Child Health Policy has found that education and school quality top the list of parental concerns in the state.

By Jake Lowary
January 6, 2022

New faculty awards honor clinical, research, teaching missions

The Office of Research, the Office of Faculty Affairs, and the Basic Sciences have created four new faculty awards named to honor and recognize past and current leadership in the clinical, educational, and research missions of Vanderbilt University School of Medicine.

By VUMC News and Communications
January 4, 2022

Opioid use disorder treatment access increases in areas with large Medicaid population

By Jill Clendening
From left, Nicholas Negretti, PhD, Jonathan Kropski, MD, John Benjamin, MD, MPH, Jennifer Sucre, MD, and Erin Plosa, MD, led the research team that created a single-cell “atlas” of lung development. (photo by Erin O. Smith)
December 20, 2021

“Atlas” of lung development may aid efforts to heal premature lungs

Researchers at Vanderbilt University Medical Center have constructed a single-cell “atlas” of lung development that tracks multiple cell types over time.

By Bill Snyder
December 16, 2021

Two VUMC papers named among genomic medicine’s top 10

Vanderbilt researchers wrote two of the “top 10” papers representing key advances in genomic medicine published between September 2020 and August 2021.

By Bill Snyder
December 16, 2021

Ess, Warren, Williams elected to American Pediatric Society

Three Vanderbilt pediatricians have been elected to the American Pediatric Society, one of the nation’s oldest and most renowned academic societies.
By Rachel Vitolo
December 8, 2021

International study supports dupilumab for treatment of moderate-to-severe asthma in children

In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients.
By Leigh MacMillan
December 8, 2021

Weigh risks, plan ahead prior to gathering for the holidays

Vanderbilt University Medical Center infectious disease experts advise this is the season to think very wisely about planned get-togethers.
By Jill Clendening
December 8, 2021

Treating children with cancer requires a strong blood supply; donations critically needed

By Kathy Whitney
December 7, 2021

VUMC awarded CDC funding to combat antimicrobial resistance, infectious diseases

Vanderbilt has partnered with the CDC to combat the crisis of antimicrobial resistance and other healthcare threats through a newly created Global Action in Healthcare Network (GAIHN).
By Jessica Pasley
December 6, 2021

Potential Rett syndrome drug shows promising results in phase 3 trial

A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.
By Craig Boerner
December 6, 2021

VUMC mourns loss of pediatric immunology expert Lawton

Alexander R. “Sandy” Lawton III, MD, emeritus professor of Pediatrics, died earlier this fall at 82.
By Rachel Vitolo
1 … 14 15 16 17 18 … 52